【Product name】Invokana, Canalia, INVOKAMET
[English common name]Canagliflozin
[Chinese common name]Cageline
[Chinese other name]Cangliet
[Indications] INVOKAMET XR is a sodium-glucose co-transport 2 (SGLT2) inhibitor and a bismuth combination product expressed as an auxiliary diet and exercise to improve glycemic control in adultsType 2 diabetesBoth cagliflozin and metformin treatments are appropriate.
[Usage and Dosage] According to the patient's current program personality.
Eat two slices and eat once a day in the morning.
In patients who have not been treated with any of the gemcitabine or metformin, there are currently two INVOKAMET XR tablets containing 50 mg of gemcitabine and 500 mg of metformin per tablet.
In patients who have been treated with cagliflozin and metformin, switch to the same total daily dose containing the same as cardinol and the same, or metformin, the nearest appropriate daily total dose of 2 INVOKAMET XR tablets.
In patients who require additional glycemic control to take a total daily dose of 100 mg of calpaparin, the dose of INVOKAMET XR can be increased to 300 mg once a day. No more than 300 mg of total daily calcareal net dose.
The dose of metformin was gradually escalated to reduce gastrointestinal side effects while no more than 2000 mg total daily dose was initiated and the pre-renal function was assessed periodically thereafter.
[Storage] Store at 25 ° C (77 ° F); Allowable temperature is 15 to 30 ° C (59 to 86 ° F)
[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.